Tag: Clinical trials
Global webcast: what we are learning from clinical trials
How all trials, successful or not, inform future research
الفائزون بزمالة مكدونالد ومنح دو بري لعام 2022
MSIF is proud to announce the recipients of the 2022 McDonald Fellowships and Du Pré Grants, from Mongolia, Brazil, Argentina and India.
التحديات التي تواجه البحث في مرض التصلب العصبي المتعدد
Thousands of scientists are undertaking research into all aspects of MS, furthering our understanding of the disease and how to prevent, treat and manage it.
باحثون يعززون الرابط بين فيروس إبشتاين بار وخطر الإصابة بالتصلّب العصبي المُتعدّد
Does EBV cause MS?
ما هي العلاجات المعتمدة للأطفال والشباب ذوي التصلب العصبي المتعدد؟
We look into these in more detail to understand how the treatment decisions are made by regulators.
2021 McDonald Fellowships and Du Pré Grant recipients announced
MSIF is proud to announce the recipients of the 2021 McDonald Fellowships and Du Pré Grants, from Argentina, Brazil, Egypt, Iran, and Tunisia
الفائز بجائزة "المحققون الشباب" لعام 2021
Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS
Clinical research and trials
Research and clinical trials are taking place around the world, trying to find and improve treatments for MS
الإعلان عن الفائزين بزمالات مكدونالد ومِنَحة Du Pré Grant لعام 2020
MSIF is proud to announce the recipients of the 2020 McDonald Fellowships and Du Pré Grants, from Iran, Zambia, Brazil, Turkey, and Argentina
الفائزة بجائزة ’المحققون الشباب‘ لعام 2020
Helen Onuorah receives the 2020 Young Investigator Award on her project "Racial inequalities in MS research participation"
تجارب سريرية في سن الطفولة والمراهقة - تحديثٌ لتوافُق عالمي في الآراء
The International Pediatric MS Study Group (IPMSSG) have updated recommendations for standards in pediatric clinical trials.
ارتباط اللحوم الحمراء غير المعلّبة بانخفاض خطر الإصابة بالتصلّب العصبي المتعدد
New research on the relationship between processed and non-processed red meat consumption and the risk of developing MS